[
    [
        {
            "time": "",
            "orginal_text": "人福医药：去年实现净利润8.4亿同比扭亏为盈，麻醉药品毛利占比4成",
            "features": {
                "keywords": [
                    "人福医药",
                    "净利润",
                    "扭亏为盈",
                    "麻醉药品",
                    "毛利占比"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "人福医药：去年实现净利润8.4亿同比扭亏为盈，麻醉药品毛利占比4成",
            "scores": {
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "人福医药(600079.SH)拟申请注册发行不超25亿元超短期融资券",
            "features": {
                "keywords": [
                    "人福医药",
                    "注册发行",
                    "超短期融资券",
                    "25亿元"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "original_text": "人福医药(600079.SH)拟申请注册发行不超25亿元超短期融资券",
            "scores": {
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "鹰眼预警：人福医药处置资产等现金收益/净利润逾60%",
            "features": {
                "keywords": [
                    "人福医药",
                    "处置资产",
                    "现金收益",
                    "净利润",
                    "60%"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "鹰眼预警：人福医药处置资产等现金收益/净利润逾60%",
            "scores": {
                "News_content": "鹰眼预警：人福医药处置资产等现金收益/净利润逾60%",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]